JPMorgan BetaBuilders U.S. Equity ETF (BATS:BBUS – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 116,679 shares, an increase of 87.5% from the September 30th total of 62,239 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 229,874 shares, the days-to-cover ratio is currently 0.5 days.
JPMorgan BetaBuilders U.S. Equity ETF Stock Down 0.5%
BATS:BBUS opened at $135.46 on Tuesday. JPMorgan BetaBuilders U.S. Equity ETF has a twelve month low of $113.43 and a twelve month high of $141.25. The company has a fifty day moving average of $138.46 and a 200-day moving average of $131.45. The firm has a market capitalization of $6.07 billion, a P/E ratio of 25.39 and a beta of 1.02.
Institutional Investors Weigh In On JPMorgan BetaBuilders U.S. Equity ETF
A number of large investors have recently bought and sold shares of BBUS. Cornerstone Planning Group LLC acquired a new position in shares of JPMorgan BetaBuilders U.S. Equity ETF during the first quarter valued at about $70,000. William Mack & Associates Inc. bought a new position in shares of JPMorgan BetaBuilders U.S. Equity ETF during the 3rd quarter worth about $101,000. Orion Capital Management LLC bought a new position in shares of JPMorgan BetaBuilders U.S. Equity ETF during the 2nd quarter worth about $145,000. Fifth Third Bancorp acquired a new stake in shares of JPMorgan BetaBuilders U.S. Equity ETF in the 1st quarter valued at about $152,000. Finally, Root Financial Partners LLC acquired a new stake in shares of JPMorgan BetaBuilders U.S. Equity ETF in the 1st quarter valued at about $166,000.
About JPMorgan BetaBuilders U.S. Equity ETF
The JPMorgan BetaBuilders U.S. Equity ETF (BBUS) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of US equities, selected and weighted by market cap. BBUS was launched on Mar 12, 2019 and is managed by JPMorgan Chase.
See Also
- Five stocks we like better than JPMorgan BetaBuilders U.S. Equity ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for JPMorgan BetaBuilders U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan BetaBuilders U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
